Molina Healthcare (NYSE:MOH – Free Report) had its target price raised by Truist Financial from $205.00 to $250.00 in a report released on Tuesday morning, MarketBeat Ratings reports. They currently have a hold rating on the stock.
Several other equities analysts have also issued reports on the company. Sanford C. Bernstein set a $286.00 price target on Molina Healthcare in a research note on Monday. Weiss Ratings raised Molina Healthcare from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, June 25th. UBS Group raised their price objective on Molina Healthcare from $180.00 to $202.00 and gave the company a “neutral” rating in a research note on Friday, May 22nd. Zacks Research raised Molina Healthcare from a “strong sell” rating to a “hold” rating in a research note on Monday, April 20th. Finally, JPMorgan Chase & Co. increased their target price on shares of Molina Healthcare from $169.00 to $191.00 and gave the stock a “neutral” rating in a report on Monday, June 8th. Three research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $207.06.
Check Out Our Latest Report on Molina Healthcare
Molina Healthcare Stock Performance
Molina Healthcare (NYSE:MOH – Get Free Report) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.78. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The business had revenue of $10.80 billion for the quarter, compared to analysts’ expectations of $10.91 billion. During the same period last year, the firm posted $6.08 earnings per share. The firm’s quarterly revenue was down 3.1% compared to the same quarter last year. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, equities research analysts forecast that Molina Healthcare will post 5.23 earnings per share for the current fiscal year.
Insider Transactions at Molina Healthcare
In other news, CAO Maurice Hebert sold 600 shares of the business’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the sale, the chief accounting officer directly owned 12,815 shares in the company, valued at approximately $2,454,713.25. The trade was a 4.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Jeff D. Barlow sold 17,811 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the transaction, the insider directly owned 67,175 shares of the company’s stock, valued at $12,502,611. This represents a 20.96% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 1.44% of the company’s stock.
Institutional Investors Weigh In On Molina Healthcare
A number of institutional investors have recently added to or reduced their stakes in MOH. AQR Capital Management LLC raised its stake in Molina Healthcare by 217.0% during the third quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock worth $561,475,000 after buying an additional 2,008,458 shares during the last quarter. 8 Knots Management LLC bought a new stake in Molina Healthcare during the fourth quarter valued at $198,942,000. Maverick Capital Ltd. acquired a new stake in Molina Healthcare during the 1st quarter worth about $86,081,000. Madison Avenue Partners LP acquired a new stake in Molina Healthcare during the 4th quarter worth about $110,003,000. Finally, Norges Bank acquired a new stake in Molina Healthcare during the 4th quarter worth about $109,766,000. 98.50% of the stock is owned by institutional investors.
About Molina Healthcare
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
See Also
- Five stocks we like better than Molina Healthcare
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
